Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Transition to 90% Telemedicine: Q&A with Karim Masri, MD

Susan Bernstein  |  April 9, 2020

How are COVID-19 and current restrictions on physical distancing affecting rheumatologists? The Rheumatologist interviewed Karim Masri, MD, to ask how the pandemic has changed the way he and his clinic staff deliver patient care, and how these unprecedented times affect patients, staff and life outside the office.

Dr. Masri is a practicing rheumatologist at Bon Secours Rheumatology Center, Richmond, Va. He earned his medical degree at the American University of Beirut, Lebanon. He completed his internal medicine residency at the University of Kansas School of Medicine, Wichita, followed by a rheumatology fellowship at the Johns Hopkins University School of Medicine, Baltimore.

Karim Masri, MD

Q: How are you and your staff adapting to the sudden changes brought about by the pandemic?
It was difficult initially. As the shockwave of the pandemic became real and the mandate that we have to avoid each other to minimize spread, our acceptance of what needs to be done and implementing it happened rapidly. Staff have recruited their families to help with childcare while they are at work. Puppies still go to playgroup.

Q: What types of appointments are you conducting?
We’ve transitioned to telemedicine almost 90%, either via Doxy.me or Epic MyChart, or by telephone calls if patients do not have access to telemedicine technology. New patients are still being seen in person for first-time visits according to the providers’ choice. We are not changing or adjusting any patients’ immunosuppression treatments. We are prescribing as normal.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Q: What are you telling patients about COVID-19’s potential risks and symptoms? What are their chief concerns?
We are telling our patients not to withhold their immunosuppressive treatments, so they minimize their risk of a flare. A flare would require taking prednisone, which is worse than their immunosuppressive therapy when it comes to infection risk. We are counseling [contact] avoidance with social distancing and remaining home, if possible. This is allergy season, so we are disseminating education on the differences between allergies and viral infections. Patients are able to get access to care via telemedicine. Lab testing is also being ordered for patients preferring telemedicine.

Q: How is this affecting you and your staff personally?
I do not speak on behalf of my staff or my employer, Bon Secours Mercy Health (BSMH), but the risk of furlough was the biggest concern for staff due to BMSH reporting last week. But thankfully, it has not affected staffing in our clinic yet. Frustration weighs heavy during this time financially, because some staff do not have savings to rely on, while others have savings locked in the market.

Page: 1 2 | Single Page
Share: 

Filed under:Practice Support Tagged with:coronavirusCOVID-19telemedicine

Related Articles

    The Doctor Will See You Now: Legal & Regulatory Reforms Expand Telemedicine

    March 17, 2020

    In this time of COVID-19, you may be considering ways to deliver routine rheumatologic care via some form of telemedicine. Here are some of the legal considerations.

    Practicing Telemedicine Raises Legal Considerations for Rheumatologists

    July 12, 2016

    With the evolution and advancement of technology, it was only a matter of time before such changes affected the medical industry. Although the concept of telemedicine dates back more than 50 years, emphasis on cost-effective quality healthcare coupled with technological advancements has caused a resurgence of telemedicine in recent years. What constitutes telemedicine largely depends…

    Telemedicine & Fellowship Education After COVID-19: Q&A with Kanika Monga, MD

    July 14, 2020

    The COVID-19 pandemic is reshaping clinical rheumatology and the fellowship experience. Rheumatology education should include how to triage patients for remote visits, says second-year fellow Kanika Monga, MD…

    The ACR Releases New Telemedicine Position Statement

    July 6, 2020

    The rapid expansion of telemedicine in rheumatology, as well as changes to reimbursement and relaxed regulations, during the COVID-19 pandemic has served as an impetus for the ACR to review its position and release a new statement in support of optimized telemedicine practices.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences